SCHEMBL4710750

SCHEMBL4710750

O=C(O)c1cnn2c(C3CCCCC3)c(-c3ccc(F)cc3)cnc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.52
AXL P30530 1/20 0.42
FLT3 P36888 1/20 0.42
TYRO3 Q06418 1/20 0.42
MERTK Q12866 1/20 0.42
PTGDR Q13258 1/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.40
CAMKK1 Q8N5S9 4/20 0.40
CAMKK2 Q96RR4 4/20 0.40
ALDH1A1 P00352 5/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
MAPT P10636 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KMT2A Q03164 2/20 0.38
KEAP1 Q14145 3/20 0.38
NFE2L2 Q16236 3/20 0.38
MEN1 O00255 1/20 0.38
GAA P10253 1/20 0.38
KDR P35968 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14014888 0.90 CAMKK2 (0.47) KDM4EAXLFLT3TYRO3MERTK
SCHEMBL14014880 0.90 KEAP1 (0.46) KDM4EAXLFLT3TYRO3MERTK
SCHEMBL6211737 0.89 CAMKK2 (0.40) KDM4ECAMKK1CAMKK2ALDH1A1NPC1
SCHEMBL14541907 0.88 CREBBP (0.46) KDM4EAXLFLT3TYRO3MERTK
SCHEMBL14014951 0.88 CAMKK2 (0.43) KDM4ECAMKK1CAMKK2ALDH1A1NPC1
SCHEMBL14014928 0.88 GABBR2 (0.42) KDM4ECAMKK1CAMKK2ALDH1A1NPC1
SCHEMBL14014957 0.87 AXL (0.41) KDM4EAXLFLT3TYRO3MERTK
SCHEMBL14014496 0.87 KDM4E (0.56) KDM4EAXLFLT3TYRO3MERTK
SCHEMBL14014941 0.86 GCGR (0.45) KDM4ECAMKK1CAMKK2ALDH1A1
SCHEMBL14014927 0.86 KDM4E (0.41) KDM4EPTGDR2CAMKK1CAMKK2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7449488-B2 Pyrazolopyrimidines as protein kinase inhibitors SCHERING CORPORATION (US) 2008-11-11 US disclosed
US-7449488-B2 Pyrazolopyrimidines as protein kinase inhibitors SCHERING CORPORATION (US) 2008-11-11 US disclosed
EP-1511751-B1 PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AS ANTIVIRAL AGENTS NEOGENESIS PHARMACEUTICALS INC (US) 2008-03-19 EP disclosed
EP-1511751-B1 PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AS ANTIVIRAL AGENTS NEOGENESIS PHARMACEUTICALS INC (US) 2008-03-19 EP disclosed
WO-2007044410-A1 PYRAZOLO [1,5-A] PYRIMIDINES AS PROTEIN KINASE INHIBITORS SCHERING CORPORATION (US) 2007-04-19 WO disclosed
US-7196111-B2 Pyrazolo[1,5a]pyrimidine compounds as antiviral agents SCHERING CORPORATION (US) 2007-03-27 US disclosed
US-7196111-B2 Pyrazolo[1,5a]pyrimidine compounds as antiviral agents SCHERING CORPORATION (US) 2007-03-27 US disclosed
EP-1511751-A1 PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AS ANTIVIRAL AGENTS Neogenesis Pharmaceuticals, Inc. (US) 2005-03-09 EP disclosed
WO-2003101993-A1 PYRAZOLO` 1,5A! PYRIMIDINE COMPOUNDS AS ANTIVIRAL AGENTS NEOGENESIS PHARMACEUTICALS, INC. (US) 2003-12-11 WO disclosed